Rein Therapeutics
RNTX
30 hedge funds and large institutions have $10.8M invested in Rein Therapeutics in 2020 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 10 closing their positions.
203% more capital invested
Capital invested by funds: $3.58M → $10.8M (+$7.25M)
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
20% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 10
7% more funds holding
Funds holding: 28 → 30 (+2)
0.83% more ownership
Funds ownership: 0.45% → 1.28% (+0.83%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$247K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$108K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$102K |
| 4 |
GPFA
Game Plan Financial Advisors
Westlake,
Ohio
|
+$85.6K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$77.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$712K |
| 2 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$340K |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$196K |
| 4 |
MS
Maven Securities
St Helier,
Jersey
|
-$106K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$56K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SFS
26
Sowell Financial Services
North Little Rock,
Arkansas
| $10K | +$11.8K | +471 | New |
|
27
Osaic Holdings
Scottsdale,
Arizona
| $2K | +$2.77K | +111 | New |
|
|
AF
28
Allworth Financial
Folsom,
California
| $1K | – | – | – |
|
29
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $1K | – | – | – |
|
|
ECM
30
Endurant Capital Management
San Mateo,
California
| – | -$340K | -13,172 | Closed |
|
|
MS
31
Maven Securities
St Helier,
Jersey
| – | -$106K | -4,250 | Closed |
|
|
32
Citadel Advisors
Miami,
Florida
| – | -$56K | -2,153 | Closed |
|
|
WS
33
Wedbush Securities
Los Angeles,
California
| – | -$45K | -1,750 | Closed |
|
|
MA
34
Mutual Advisors
Omaha,
Nebraska
| – | -$20K | -765 | Closed |
|
35
Millennium Management
New York
| – | -$19 | -744 | Closed |
|
36
UBS Group
Zurich,
Switzerland
| – | -$7K | -264 | Closed |
|
|
TRCT
37
Tower Research Capital (TRC)
New York
| – | -$5K | -203 | Closed |
|
|
CCM
38
Cribstone Capital Management
Augusta,
Maine
| – | -$4K | -164 | Closed |
|
RNTX Hedge Fund Activity: Q4 2020 in Review
30 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Rein Therapeutics (RNTX) for Q4 2020, worth a combined $10.8M — up 203% from $3.58M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new RNTX positions and 10 closed out — a net gain of 2 holders — while 5 added to existing stakes and 4 trimmed.
The largest buyer was Vanguard Group, adding an estimated $247K. The largest seller was Renaissance Technologies, cutting an estimated $712K.
- 30 institutional investors held Rein Therapeutics (RNTX) as of Q4 2020, up from 28 in Q3 2020.
- Funds reported $10.8M of Rein Therapeutics stock for Q4 2020, up 203% quarter-over-quarter.
- 12 funds opened new Rein Therapeutics positions in Q4 2020 and 10 closed out, a net change of +2 holders.
- The largest Rein Therapeutics buyer in Q4 2020 was Vanguard Group, an estimated $247K added.
- The largest Rein Therapeutics seller in Q4 2020 was Renaissance Technologies, an estimated $712K sold.
Based on aggregated 13F filings for Q4 2020.